secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2024-06-21T23:59:59+00:00
Accession:  0001411690-24-000040
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Bionano Genomics stockholders elect three Class III directors, approve say-on-pay, ratify auditor at 2024 meeting
--------------------------------------------------------------------------------

- Elected Christopher Twomey, Yvonne Linney, and Aleksander Rajkovic as Class III directors until 2027.
- Advisory vote on executive compensation approved: 9,508,999 for, 1,771,611 against, 642,388 abstentions.
- Ratification of BDO USA as independent auditor for FY 2024 approved: 26,950,772 for, 2,788,563 against, 308,349 abstentions.
- Approximately 44.94% of outstanding shares (30,047,684) were represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000141169024000040/0001411690-24-000040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000141169024000040/bngo-20240618.htm
  HTML page:      https://secwatch.observer/filing/0001411690-24-000040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer